Amanpour and Company
A New Pill Finally Offers Hope for Pancreatic Cancer
Dr. Mark Goldsmith discusses his company's breakthrough development in pancreatic cancer treatment.
Latest in
Amanpour and Company
Sponsorship
Amanpour and Company
Has the U.S. “Already Lost” the War in Iran?
Robert Kagan discusses America's limited options in the war with Iran.
Amanpour and Company
SNAP Faces $187 Billion in Cuts. Who Is Paying the Price?
Public policy expert Sara Naomi Bleich on the impact of losing SNAP access.